GIFT a SubscriptionGift
HamberMenu
  1. Cricket
  2. Data
  3. Health
  4. Opinion
  5. SEARCH Icon
  1. Cricket
  2. Data
  3. Health
  4. Opinion
  5. SEARCH Icon

To enjoy additional benefits

GIFT a SubscriptionGift
ShowcaseCrossword+

CONNECT WITH US

year
Click here for our in-depth coverage of Lok Sabha and Assembly elections #ElectionsWithTheHindu

The Novartis Saga: a timeline

Novartis had sought to overturn a clause in Indian Patents Law that restricts patent protection for newer forms of existing molecules. The case started in 1997 when Novartis filed a plea for a patent for Glivec.

April 02, 2013 03:14 am | Updated December 04, 2021 11:39 pm IST

Following is the timeline of the patent case in India.

1997 : Novartis files a patent application in India for its drug Gilvec

2005 : India introduces the Indian Patent Act preventing frivolous patents.

Jan 2006 : The Patent Controller in Chennai denies Novartis a patent

May 2006 : Novartis challenges the Indian government and four other companies in the Madras High Court

Aug 2007 : The Madras High Court rules against Novartis’ case

June 2009 : The Intellectual Property Appellate Board rejects a fresh appeal

August 2009 : Novartis approaches the Supreme Court of India

April 1, 2013 : Supreme Court rejects Novartis’ plea for patent

Related stories

Related Topics

pharmaceutical / litigation and regulation / patent, copyright and trademark

Top News Today

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.